In this issue of Clinics in Laboratory Medicine, guest editors Drs. Christopher P. Holstege and Joshua D. King bring their considerable expertise to the topic of COVID-19 Molecular Testing and Clinical Correlates. Top experts in the field cover key topics such as point-of-care molecular assays for SARS-CoV-2; strategies for scaling up SARS-CoV-2 molecular testing capacity; cycle threshold values from SARS-CoV-2 PCR assays; and more.
Contains 12 relevant, practice-oriented topics including analytic and clinical performance of major commercial SARS-CoV-2 PCR assays in the United States; isothermal assays for SARS-CoV-2 detection; rapid antigen assays for SARS-CoV-2; approaches to deployment of molecular testing for SARS-CoV-2 in resource-limited settings; and more.
Provides in-depth clinical reviews on COVID-19 molecular testing and clinical correlates, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States - p. 129 9. The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States - p. 147 10. An Overview of SARS-CoV-2 Molecular Diagnostics in Europe - p. 161 11. SARS-CoV-2 Molecular Diagnostics in China - p. 193 12. Rapid Antigen Assays for SARS-CoV-2: Promise and Peril - p. 203 13. Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2 - p. 223 14. Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays: Interpretation and Potential Use Cases - p. 237 15. Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2 - p. 249 16. Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity - p. 261 17. Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings - p. 283 18. Novel Assays for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 - p. 299
In this issue of Clinics in Laboratory Medicine, guest editors Drs. Christopher P. Holstege and Joshua D. King bring their considerable expertise to the topic of COVID-19 Molecular Testing and Clinical Correlates. Top experts in the field cover key topics such as point-of-care molecular assays for SARS-CoV-2; strategies for scaling up SARS-CoV-2 molecular testing capacity; cycle threshold values from SARS-CoV-2 PCR assays; and more.
Contains 12 relevant, practice-oriented topics including analytic and clinical performance of major commercial SARS-CoV-2 PCR assays in the United States; isothermal assays for SARS-CoV-2 detection; rapid antigen assays for SARS-CoV-2; approaches to deployment of molecular testing for SARS-CoV-2 in resource-limited settings; and more.
Provides in-depth clinical reviews on COVID-19 molecular testing and clinical correlates, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States - p. 129 9. The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States - p. 147 10. An Overview of SARS-CoV-2 Molecular Diagnostics in Europe - p. 161 11. SARS-CoV-2 Molecular Diagnostics in China - p. 193 12. Rapid Antigen Assays for SARS-CoV-2: Promise and Peril - p. 203 13. Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2 - p. 223 14. Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays: Interpretation and Potential Use Cases - p. 237 15. Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2 - p. 249 16. Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity - p. 261 17. Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings - p. 283 18. Novel Assays for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 - p. 299
